The University of Chicago Header Logo

Connection

Dezheng Huo to Transforming Growth Factor alpha

Back to Details
This is a "connection" page, showing publications Dezheng Huo has written about Transforming Growth Factor alpha.
Dezheng Huo
Connection Strength
0.015
Transforming Growth Factor alpha
  1. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005 Dec 01; 11(23):8418-24.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.